Outlook on the Worldwide Biotechnology Reagents Industry to 2027 – Agreements, Partnerships and Collaborations & Joint Ventures – Yahoo Finance
♫ Thursday, June 4th, 2020Dublin, June 02, 2020 (GLOBE NEWSWIRE) -- The "Biotechnology Reagents - Global Market Outlook (2018-2027)" report has been added to ResearchAndMarkets.com's offering.
The Global Biotechnology Reagents market accounted for $69.21 billion in 2018 and is expected to reach $163.19 billion by 2027 growing at a CAGR of 10.0% during the forecast period. Rising number of biotechnology firms and growth in biopharmaceuticals are the major factors propelling the market growth. However, high cost of reagents is hampering the market growth.
Biotechnology reagents are the substances used to detect or synthesize another substance so as to provide a test reading. The biotechnological reagents play an important role in the age of rapid research, discovery, and publication in the industry and academic research purposes.
Based on the technology, the analytical segment is going to have a lucrative growth during the forecast period as chromatography technique of analytical technology is mostly used in drug discovery to validate the specificity, sensitivity, and purity of drugs and deliver precise outcomes to validate characters. By geography, North America is going to have a lucrative growth during the forecast period owing to high investments, new product developments, presence of favorable government policies and sophisticated healthcare infrastructure.
Some of the key players profiled in the Biotechnology Reagents Market include Siemens Healthineers, Quality Biological Inc., Merck Millipore, PerkinElmer, Meridian Bioscience, Promega Corporation, Lonza Group AG, BioMrieux, GE Healthcare, Bio-Rad Laboratories, Life Technologies, Beckman Coulter, Agilent Technologies, Abbott Laboratories and Becton Dickinson.
What our report offers:
Key Topics Covered:
1 Executive Summary
2 Preface2.1 Abstract 2.2 Stake Holders 2.3 Research Scope 2.4 Research Methodology2.4.1 Data Mining2.4.2 Data Analysis2.4.3 Data Validation2.4.4 Research Approach2.5 Research Sources 2.5.1 Primary Research Sources 2.5.2 Secondary Research Sources 2.5.3 Assumptions
3 Market Trend Analysis3.1 Introduction 3.2 Drivers 3.3 Restraints 3.4 Opportunities 3.5 Threats 3.6 Technology Analysis 3.7 Application Analysis 3.8 End User Analysis 3.9 Emerging Markets 3.10 Impact of Covid-19
4 Porters Five Force Analysis
5 Global Biotechnology Reagents Market, By Technology5.1 Introduction 5.2 Life Science 5.2.1 Polymerase Chain Reaction 5.2.1.1 Master Mixes 5.2.1.2 Kits5.2.1.3 Individual Reagent 5.2.2 Cell/Tissue Culture5.2.2.1 Sera5.2.2.2 Media and Regents 5.2.3 In-Vitro Diagnostics5.2.3.1 Microbiology Culture 5.2.3.2 Hematology 5.2.3.3 Immunoassay 5.2.3.4 Clinical Chemistry 5.2.3.5 Molecular Diagnostics 5.2.4 Expression and Transfection 5.3 Analytical 5.3.1 Chromatography5.3.1.1 Super Critical Fluid Chromatography5.3.1.2 Liquid Chromatography 5.3.1.3 Ion Chromatography 5.3.1.4 Gas Chromatography 5.3.1.5 Reagents Type 5.3.1.5.1 Solvent 5.3.1.5.2 Chemical 5.3.1.5.3 Adsorbents 5.3.2 Mass Spectrometry5.3.2.1 Proteomics 5.3.2.2 Drug Discovery 5.3.2.3 Clinical Testing 5.3.2.4 Genomics5.3.3 Electrophoresis5.3.3.1 Gel5.3.3.2 Dye5.3.3.3 Buffer5.3.4 Flow Cytometry5.3.4.1 Cell-based Flow Cytometry 5.3.4.2 Bead-based Flow Cytometry
6 Global Biotechnology Reagents Market, By Application6.1 Introduction 6.2 Protein Synthesis and Purification 6.3 Immunophenotyping 6.4 Gene Expression 6.5 Fluorescent Microscopy6.6 Drug testing 6.7 DNA and RNA analysis6.8 Cell Cycle Analysis
7 Global Biotechnology Reagents Market, By End User7.1 Introduction 7.2 Research Institutes 7.3 Pharmaceuticals 7.4 Diagnostic Centers 7.5 Biotech Companies
8 Global Biotechnology Reagents Market, By Geography8.1 Introduction 8.2 North America 8.2.1 US 8.2.2 Canada 8.2.3 Mexico 8.3 Europe 8.3.1 Germany 8.3.2 UK 8.3.3 Italy 8.3.4 France 8.3.5 Spain 8.3.6 Rest of Europe8.4 Asia Pacific 8.4.1 Japan 8.4.2 China 8.4.3 India 8.4.4 Australia 8.4.5 New Zealand8.4.6 South Korea8.4.7 Rest of Asia Pacific8.5 South America 8.5.1 Argentina 8.5.2 Brazil 8.5.3 Chile 8.5.4 Rest of South America 8.6 Middle East & Africa 8.6.1 Saudi Arabia8.6.2 UAE 8.6.3 Qatar 8.6.4 South Africa8.6.5 Rest of Middle East & Africa
9 Key Developments9.1 Agreements, Partnerships, Collaborations and Joint Ventures9.2 Acquisitions & Mergers9.3 New Product Launch 9.4 Expansions 9.5 Other Key Strategies
10 Company Profiling10.1 Siemens Healthineers10.2 Quality Biological Inc.10.3 Merck Millipore 10.4 PerkinElmer 10.5 Meridian Bioscience 10.6 Promega Corporation10.7 Lonza Group AG 10.8 BioMrieux 10.9 GE Healthcare 10.10 Bio-Rad Laboratories10.11 Life Technologies 10.12 Beckman Coulter 10.13 Agilent Technologies 10.14 Abbott Laboratories 10.15 Becton Dickinson
For more information about this report visit https://www.researchandmarkets.com/r/y9konb
Story continues
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: ResearchAndMarkets.comLaura Wood, Senior Press Managerpress@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900